Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06208631 · ClinicalTrials.gov registry record · NA

Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis

A NA study of Osteoarthritis, Knee, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT06208631: Recruiting NA study of Osteoarthritis, Knee, sponsored by Stanford University.

NCT06208631 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by Stanford University. The registered enrollment target is 31 participants, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06208631, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This study investigates how well individuals with knee osteoarthritis can learn to alter their calf muscle activation using haptic biofeedback while walking and evaluates how these changes affect knee loading. Prior research has utilized musculoskeletal simulations to determine that reducing the activation of one of the calf muscles, the gastrocnemius, can have a large impact on reducing knee loading. However, this has not been tested in individuals with knee osteoarthritis. In this study, participants will be trained to alter the activation of their gastrocnemius muscle, by receiving haptic feedback after each step. The feedback will indicate how the participant changed their muscle activation relative to baseline. Some participants will train on a treadmill in the laboratory for up to two sessions, with 30 minutes of walking with feedback in each session. If a participant can learn to adjust their muscle activation in the first training session, they will be able to complete the second training session. Other participants will train outside the laboratory for one session with 30 minutes of walking with feedback to investigate changes in knee loading while using the new walking strategy during over-ground walking. The movement data collected during the training sessions will be used as inputs to computer simulations of the musculoskeletal system to determine if walking with the new muscle activation strategy reduces knee loading.

Primary Outcome

Knee contact force will be evaluated using motion capture data and musculoskeletal modeling and simulations, for participants that are able to reduce gastrocnemius activation.

Conditions Studied

Interventions

  • BEHAVIORAL Gait retraining

Study Locations (1)

California

  • Stanford Human Performance Lab - Stanford

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2024-01-18
Est. Completion 2026-12
Phase NA
Stanford University

1,744 total trials

What NCT06208631 shows while recruiting

NCT06208631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 497-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Gait retraining is the first listed.

NCT06208631 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06208631 about?

NCT06208631 is a clinical study titled "Effects of Movement Retraining on Knee Loading in Individuals With Knee Osteoarthritis". This study investigates how well individuals with knee osteoarthritis can learn to alter their calf muscle activation using haptic biofeedback while walking and evaluates how these changes affect knee loading. Prior research has utilized musculoskeletal simulations to determine that reducing the ac...

What is the current status of trial NCT06208631?

This trial is currently recruiting. It is a NA study. The enrollment target is 31 participants. The study started on 2024-01-18. Estimated completion is 2026-12.

What conditions does trial NCT06208631 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT06208631?

The interventions under investigation include: Gait retraining (BEHAVIORAL).

Who is sponsoring clinical trial NCT06208631?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06208631 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06208631's enrollment target sits among peer trials

31 100th of 112 higher than 13 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06208631, the US trial registry maintained by the National Library of Medicine. NCT06208631 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.